The myAirvo therapy system – humidified high flow for home use

Ease symptoms.
Reduce escalation of care.
Improve quality of life.

Request information

Buy Now
Frequent coughs, breathlessness and hospitalization can seriously impact the wellbeing of patients with respiratory conditions such as chronic obstructive pulmonary disease (COPD). The myAirvo™ system delivers humidified high flow therapy to chronic respiratory patients at home and in long-term care facilities.

Humidified high flow therapy delivers a mix of warm, moist air and supplementary oxygen (when required) to help COPD patients:

Ease respiratory disease symptoms1,2,5
Reduce escalation of care1,3,5
Improve quality of life1-5

The search is on to find better treatments for chronic obstructive pulmonary disease (COPD) patients.

More than 15.7 million Americans report being diagnosed with COPD, so we’re delighted to be supporting a clinical trial, HiFlo COPD, evaluating the effect of nasal high flow therapy in COPD patients in the home.

The multi-center trial is being led by Temple University Hospital in Philadelphia.

Find out more

myAirvo 2

Deliver Optimal Humidity using advanced respiratory technology with myAirvo 2.

Optiflow™ interfaces

Ensure comfort and fit with a range of nasal cannulas, tracheostomy and mask adapter interfaces, including pediatric sizes.


For the delivery of humidified high flow therapy in hospitals

Airvo 2™ delivers nasal high flow therapy to a broad range of patients in all areas of the hospital.

Learn more about Airvo 2
F&P, myAirvo, Airvo and Optiflow are trademarks of Fisher & Paykel Healthcare Limited. For patent information, see